MaxiVAX starts anti-cancer clinical trial based on active immunotherapy
Novel high-tech anti-cancer vaccination therapy boosts the patient’s own immune response
17-Nov-2014 -
MaxiVAX SA is conducting a clinical phase 1 trial at the Geneva University Hospitals with its proprietary cancer vaccination MVX-ONCO-1 in 15 patients suffering from various cancers at an advanced stage.The Immuno-Oncology therapeutic protocol and product of MaxiVAX is based on boosting the ...
cancer
phase I studies
vaccines